NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Company Overview - NeuroPace, Inc. is a medical device company based in Mountain View, California, focused on transforming the lives of people living with epilepsy by reducing or eliminating debilitating seizures [3] - The company has developed the RNS System, which is the first and only commercially available brain-responsive platform that delivers personalized, real-time treatment at the seizure source [3] - This platform aims to improve the standard of care for patients with drug-resistant epilepsy and has potential applications for other brain disorders [3] Financial Reporting - NeuroPace will report its financial results for the fourth quarter and full year of 2024 after market close on March 4, 2025 [1] - A conference call will be held at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss these results [1] Investor Engagement - Investors can access the conference call via a live and archived webcast [2] - For those wishing to participate by telephone, the call can be accessed by dialing +1-877-407-3982 and referencing Conference ID 13751530 [2] - The webcast will be available for replay for at least 90 days after the event [2]